logo
Gynaecologist warns of rising lung cancer risk among women who spend hours in kitchen: ‘Cooking fumes can be dangerous'

Gynaecologist warns of rising lung cancer risk among women who spend hours in kitchen: ‘Cooking fumes can be dangerous'

Hindustan Times3 days ago
Lung cancer has long been seen as a man's disease, but rates among women are climbing at an alarming pace. Shifts in smoking habits, environmental exposures and hormonal influences all play a part. Yet many women remain unaware they're at risk until it's too late. Dr Bác Sĩ Chiều, a Vietnam-based gynaecologist specialising in cancer, shared in his June 5 Instagram post the surprising factors behind this rise and why urgent awareness is crucial. (Also read: Impact of high AQI on lungs: Lung cancer on the rise among 'never smokers'; 3 things to do according to doctor ) Cooking fumes linked to rising lung cancer rates in women, expert warns. (Unsplash)
Could your kitchen be harming your lungs
Dr Bác shared in his post, 'Lung cancer in housewives and women who cook at home is becoming more common. One woman asked me, 'Why do I have lung cancer when no one in my family smokes?' So I asked her: When you cook, does the smell of oil and smoke rise up a lot? Do you open windows to let the air circulate? Do you use a kitchen hood or exhaust fan?' Her answer was no; her kitchen was very enclosed.'
Importance of ventilation for lung health
He continued, 'She told me she rarely interacts with smokers and spends most of her time at home. But she's constantly exposed to cooking fumes, sometimes for 30 minutes, an hour, or even more each day. Of course, the causes of lung cancer are complex. It's not solely because of cooking or being in the kitchen. But poor ventilation and breathing in fumes every day definitely affect the lungs.'
Dr Bác explains that improving air circulation in the kitchen is a simple yet powerful step for protecting lung health. 'It's such a small change, but it can make a big difference,' he adds.
Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

JNUSU president hospitalised amid ongoing hunger stir
JNUSU president hospitalised amid ongoing hunger stir

The Hindu

time3 hours ago

  • The Hindu

JNUSU president hospitalised amid ongoing hunger stir

Jawaharlal Nehru University Students' Union (JNUSU) president Nitish Kumar was hospitalised on Tuesday, the 12th day of an ongoing hunger strike, after he complained of chest pain, JNUSU members said. Students have been on an indefinite hunger strike demanding the reinstatement of the Jawaharlal Nehru University Entrance Examination (JNUEE), which has been replaced with a UGC-NET-based entrance system in recent years. The other demands include increasing the merit-cum-means scholarship and revocation of hostel eviction notices for PhD scholars on academic extension. Mr. Kumar, a member of the Left-affiliated All India Students' Association (AISA), was taken to Safdarjung Hospital. Loni, a JNU student and an AISA activist, who participated in the hunger strike, was also rushed to AIIMS on Tuesday afternoon after she blacked out. Both of them are said to be in stable condition. The JNUSU, in an open letter to the JNU Teachers' Association, stated that 14 students have been on hunger strike. 'Our principal demand is the restoration of the JNUEE. This exam has long ensured that this campus remains accessible to students from diverse backgrounds across the country. Its continuation is essential for safeguarding the inclusive character and academic integrity of JNU,' the letter read.

Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Experts call for inclusion of Chronic Kidney Disease in national NCD programme

The Hindu

time3 hours ago

  • The Hindu

Experts call for inclusion of Chronic Kidney Disease in national NCD programme

Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.

Pharma lobby flags 'cumbersome' export rule, seeks change
Pharma lobby flags 'cumbersome' export rule, seeks change

Time of India

time4 hours ago

  • Time of India

Pharma lobby flags 'cumbersome' export rule, seeks change

New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store